How hydrogel–nanoparticle systems offer a promising strategy to modulate the tumor microenvironment by enabling targeted drug delivery, controlled release, enhanced tumor penetration, and improved therapeutic efficacy in breast cancer is critically discussed.
Abstract
Breast cancer accounts for one in four cancers diagnosed in women and remains the leading cause of cancer-related mortality among women worldwide. The drug delivery system (DDS) has created an effective approach in cancer treatment. The current advancement is a combination of nanomaterials with modern nanotechnological strategies, revolutionizing the DDS. Hydrogels provide an exciting route for innovative DDS to deliver various molecules, including peptides, via transdermal, vaginal, nasal, ocular, oral, and other routes. Both natural and synthetic polymeric networks of hydrogels are esteemed for their superior biocompatibility, adjustable mechanical strength, elevated water content, and capacity to encapsulate and release therapeutic agents in a regulated manner, enabling the development of various DDS, including injectable depots, localized implants, and stimuli-responsive formulations designed for specific therapeutic purposes. Hydrogel–nanoparticle systems represent a convergence of material science and cancer biology, offering unprecedented opportunities for pathway-informed drug delivery. Hydrogel-embedded nanoparticle-mediated drug delivery strategies can intentionally shift the balance between survival and death pathways rather than relying on cytotoxicity, with the potential to redefine these systems as programmable therapeutic platforms tailored to the proteomic landscape of breast cancer. Therefore, this review critically discusses how hydrogel–nanoparticle systems offer a promising strategy to modulate the tumor microenvironment by enabling targeted drug delivery, controlled release, enhanced tumor penetration, and improved therapeutic efficacy in breast cancer.
Breast cancer remains a major global health concern, highlighting the need for advanced drug delivery strategies that can improve therapeutic efficacy while minimizing systemic toxicity. Although several reviews have discussed polymeric nanocarriers for breast cancer therapy, many have primarily focused on specific p...
Nazanin Amiryaghoubi, B. Kim· ACS Applied Nano Materials· 0 citations
Abstract Challenges in cancer therapy remain in terms of lack of tumor selectivity, unwanted side effects, and inefficacy of current treatment strategies. Over the past few years, functionalized bio-polymer gels have become attractive alternatives for cancer therapy, as they are biocompatible and can be tailored to pro...
Sheng-Chun Qiu, Xiao-Yan Wen· International Journal of Nan...· 0 citations
This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...
C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al.· Materials· 0 citations
Abstract Breast cancer heterogeneity and its complex tumor microenvironment (TME) are key drivers of therapeutic failure and multidrug resistance (MDR). Drug delivery systems (DDS) provide an important approach, but their clinical translation remains limited by biological variability, formulation complexity, and manufa...
Gui-Wen Liang, Chu-Lin Zhu, Hua-Lin Sun et al.· Drug Design, Development and...· 0 citations
This comprehensive review provides details on nanocarriers and their loaded delivery systems as effective strategies for breast cancer treatment and provides an updated synthesis of nanocarrier-based approaches, focusing on recent clinical and preclinical innovations in drug delivery, diagnostics, and personalized medi...
Prerana Sahu, G. Sahu, Harish Sharma et al.· Current Cancer Therapy Revie...· 0 citations
This review systematically summarizes targeted nanomedicines constructed from mainstream carriers, including polymeric, metallic, and biomimetic nanoparticles, and discusses the future prospects of artificial intelligence-assisted optimization strategies for nanomedicine development.
Rui-Chao Li, Ze-Yuan Sun, Si-Nian Li et al.· International Journal of Pha...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.